Neurim Pharmaceuticals

Companies Neurim Pharmaceuticals

News Neurim Pharmaceuticals

• Circadin is Approved in the EU for Treatment of Primary Insomnia in Patients Aged 55 or Over for up to 3 Months

  Neurim Pharmaceuticals confirmed that the European Commission (EC) has approved a change in treatment duration with Circadin from 3 to 13 weeks (3 months). Circadin is indicated for the treatment of primary insomnia in patients who are aged 55 or over. The approval was based primarily on data obtai more

• Viroblock SA Hires Dr. Jamie Paterson as CEO

  Viroblock SA, a start-up dedicated to developing and commercializing a new generation of anti-viral products, announced that Dr. Jamie Paterson will join Viroblock as Chief Executive Officer (CEO). Jamie Paterson, a British national, can look back at 20 years of experience in the pharmaceutical ind more

Market studies Neurim Pharmaceuticals

• D-Pharm Ltd. (DPRM) - Strategic SWOT Analysis Review

  D-Pharm LTD.(D-Pharm) is a specialty bio-pharmaceutical company. It is engaged in the design and development of innovative drugs for the treatment of the brain disorders. It has developed two unique platform technologies that generate lipid–like medicines which utilizes lipid specific mechanisms and more

Websites Neurim Pharmaceuticals